https://www.selleckchem.com/pr....oducts/cyclo-rgdyk.h
01, 95% CI 1.00-1.02) were associated with worse OS. Median OS in the high- and low-risk groups were 40.5 (95% CI 34.0-45.7 months) versus 64.7 months (95% CI 57.9-72.3 months; p 0.001), respectively. We externally validated the prognostic significance of shorter TTR (8.5 months) as a predictor of worse OS in patients who recur the following hepatectomy for CRM. We externally validated the prognostic significance of shorter TTR ( less then 8.5 months) as a predictor of worse OS in patients who recur the following hepatectom
Like
Comment
Share
